Bright Minds Biosciences, Inc. (DRUG.CX)
123.50
+4.25
(+3.56%)
CAD |
CNSX |
Apr 17, 16:00
Bright Minds Biosciences Enterprise Value : 1.203B for April 17, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
Enterprise Value Related Metrics
| Normalized Earnings Yield | -0.5574 |